Literature DB >> 25077093

Gigantism caused by growth hormone secreting pituitary adenoma.

Noorisaem Rhee1, Kumi Jeong1, Eun Mi Yang1, Chan Jong Kim1.   

Abstract

Gigantism indicates excessive secretion of growth hormones (GH) during childhood when open epiphyseal growth plates allow for excessive linear growth. Case one involved a 14.7-year-old boy presented with extreme tall stature. His random serum GH level was 38.4 ng/mL, and failure of GH suppression was noted during an oral glucose tolerance test (OGTT; nadir serum GH, 22.7 ng/mL). Magnetic resonance imaging (MRI) of the brain revealed a 12-mm-sized pituitary adenoma. Transsphenoidal surgery was performed and a pituitary adenoma displaying positive immunohistochemical staining for GH was reported. Pituitary MRI scan was performed 4 months after surgery and showed recurrence/residual tumor. Medical treatment with a long-acting somatostatin analogue for six months was unsuccessful. As a result, secondary surgery was performed. Three months after reoperation, the GH level was 0.2 ng/mL and insulin-like growth factor 1 was 205 ng/mL. Case two involved a 14.9-year-old boy, who was referred to our department for his tall stature. His basal GH level was 9.3 ng/mL, and failure of GH suppression was reported during OGTT (nadir GH, 9.0 ng/mL). Pituitary MRI showed a 6-mm-sized pituitary adenoma. Surgery was done and histopathological examination demonstrated a pituitary adenoma with positive staining for GH. Three months after surgery, the GH level was 0.2 ng/mL and nadir GH during OGTT was less than 0.1 ng/mL. Pituitary MRI scans showed no residual tumor. We present two cases of gigantism caused by a GH-secreting pituitary adenoma with clinical and microscopic findings.

Entities:  

Keywords:  Gigantism; Growth hormone; Pituitary adenoma

Year:  2014        PMID: 25077093      PMCID: PMC4114045          DOI: 10.6065/apem.2014.19.2.96

Source DB:  PubMed          Journal:  Ann Pediatr Endocrinol Metab        ISSN: 2287-1012


  16 in total

Review 1.  Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly.

Authors:  S Melmed; K Ho; A Klibanski; S Reichlin; M Thorner
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

2.  Pituitary gigantism: a disabling condition.

Authors:  E M Whitehead; S M Shalet; D Davies; B A Enoch; D A Price; C G Beardwell
Journal:  Clin Endocrinol (Oxf)       Date:  1982-09       Impact factor: 3.478

3.  Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center.

Authors:  G Barrande; M Pittino-Lungo; J Coste; D Ponvert; X Bertagna; J P Luton; J Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

4.  Pediatric pituitary adenoma: a series of 42 patients.

Authors:  P Pandey; B K Ojha; A K Mahapatra
Journal:  J Clin Neurosci       Date:  2005-02       Impact factor: 1.961

5.  Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl.

Authors:  M Rix; P Laurberg; A S Hoejberg; B Brock-Jacobsen
Journal:  Eur J Endocrinol       Date:  2005-08       Impact factor: 6.664

6.  Transsphenoidal surgery for pituitary adenomas in children.

Authors:  E H Dyer; T Civit; A Visot; O Delalande; P Derome
Journal:  Neurosurgery       Date:  1994-02       Impact factor: 4.654

7.  Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy.

Authors:  Ellen Schoof; Helmuth G Dörr; Wieland Kiess; Dieter K Lüdecke; Eduard Freitag; Volker Zindel; Wolfgang Rascher; Jörg Dötsch
Journal:  Horm Res       Date:  2004-01-23

8.  Pituitary tumors in adolescent patients.

Authors:  R Artese; D H D'Osvaldo; I Molocznik; H Benencia; J Oviedo; J A Burdman; A Basso
Journal:  Neurol Res       Date:  1998-07       Impact factor: 2.448

9.  Pituitary adenomas in childhood and adolescence.

Authors:  L A Kane; M C Leinung; B W Scheithauer; E J Bergstralh; E R Laws; R V Groover; K Kovacs; E Horvath; D Zimmerman
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

Review 10.  Growth hormone measurements in the diagnosis and monitoring of acromegaly.

Authors:  Akira Sata; Ken K Y Ho
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

View more
  2 in total

1.  gp130/STAT3 signaling is required for homeostatic proliferation and anabolism in postnatal growth plate and articular chondrocytes.

Authors:  Nancy Q Liu; Yucheng Lin; Liangliang Li; Jinxiu Lu; Dawei Geng; Jiankang Zhang; Tea Jashashvili; Zorica Buser; Jenny Magallanes; Jade Tassey; Ruzanna Shkhyan; Arijita Sarkar; Noah Lopez; Siyoung Lee; Youngjoo Lee; Liming Wang; Frank A Petrigliano; Ben Van Handel; Karen Lyons; Denis Evseenko
Journal:  Commun Biol       Date:  2022-01-17

2.  Magneto-Immunoassay for the Detection and Quantification of Human Growth Hormone.

Authors:  Almira Ramanaviciene; Anton Popov; Ema Baliunaite; Benediktas Brasiunas; Asta Kausaite-Minkstimiene; Ugur Tamer; Gailute Kirdaite; Eiva Bernotiene; Ali Mobasheri
Journal:  Biosensors (Basel)       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.